{"name":"Polaryx Therapeutics, Inc.","slug":"polaryx-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":6266000,"netIncome":-8985000,"cash":5143000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"PLX-200","genericName":"PLX-200","slug":"plx-200","indication":"Advanced solid tumors (Phase 3 development)","status":"phase_3"}]}],"pipeline":[{"name":"PLX-200","genericName":"PLX-200","slug":"plx-200","phase":"phase_3","mechanism":"PLX-200 is a selective inhibitor of polo-like kinase 1 (PLK1) that disrupts cell cycle progression and induces apoptosis in cancer cells.","indications":["Advanced solid tumors (Phase 3 development)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxQenh6RGtIeXZINXo2alNsUVN0RjVxMEhwcjlCRzJ3SHQ1dnE3RVVMUlZLLUg2V3N3TC1Zd1pjNGpHRDc1Q01yVlNMallRRkdPSFBlQlFNQ0Z5MFpGUzdobG1WVDJ5dmRTS2k0bVowal9nTmpJZ3VUUHh5U3NkT2tma25GWGhiZWN2U2RxNHYxR0RlTzlSeFE3V1FoTXVvWUtXREVGUHo4RGh4UkpzanVGTHBR?oc=5","date":"2026-03-27","type":"pipeline","source":"Benzinga","summary":"12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga","headline":"12 Health Care Stocks Moving In Friday's Intraday Session","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxNeVJvbDZYTEgxQTlxVE9uQ1k5SWszc05vX3ZvQWNhOGcxNWc3dTRLVUhsLWNIbkM0Rl9xMG8tb0syeG5WZnhrV1BkZ09EQ2tHWGJIMmtqSFprdTgyT0FQRnE0cmpFVGhpUVhXcWVITF9hcjY1cUxxcnV6bFF6dFpZdXFmNHFDdTRzYzlZbkhxZDh4MHRfZUNubzRKZ3B6c2JYTEE5V0JSSlhjSEJVRFhUZHh6RW1nZF90bXRIbUR2R3RReTRzREFlUTJMZEZIZkxaUHpjY19yZGRqZm00?oc=5","date":"2026-03-24","type":"pipeline","source":"Minichart","summary":"Polaryx Therapeutics: Advancing Innovative Therapies for Rare Pediatric Lysosomal Storage Disorders (LSDs) - Minichart","headline":"Polaryx Therapeutics: Advancing Innovative Therapies for Rare Pediatric Lysosomal Storage Disorders (LSDs)","sentiment":"neutral"},{"date":"2026-03-24","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: ANNUAL REPORT","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-02-05","type":"pipeline","source":"simplywall.st","summary":"Polaryx Therapeutics (PLYX) Valuation Check After Sharp Single Day Share Price Decline - simplywall.st","headline":"Polaryx Therapeutics (PLYX) Valuation Check After Sharp Single Day Share Price Decline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxPdzlwWVRjaFJaTHhMWWtiRFI0VGo3ay1SWUxwbjN0QzBkRXMtVkI5UmFWekUzSDlBdnJaWUdXSVZNVENqeGhRREl6eDJGZWFpQlNjRkxVYm95Y2JST3hKNHljTnNOeUdEcG11TGM5Z3FqOVVKS2JPX3g4VllzN2YyYURUcnljSlYwSnRhdl9mamNfR2xBWVZwcC1SR2RQOGdvZS13a0ZTRjJXWDJibDdyOERrMGp4UEVrRV9GT3owT1VvYklsUXlWdFl3?oc=5","date":"2026-02-03","type":"regulatory","source":"Benzinga","summary":"Why Teradyne Shares Are Trading Higher By Over 22%; Here Are 20 Stocks Moving Premarket - Benzinga","headline":"Why Teradyne Shares Are Trading Higher By Over 22%; Here Are 20 Stocks Moving Premarket","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwJBVV95cUxQUzNEVTQ5RWJSblEybmR5TjRtT0w0SEJqVm03WWttQ1JKSjJSUExlSjByQmtXV1VBZEZhMXpGNFJxVm9FVW1rTTdKVkZBM3Z3QVdnaTJoMndTMzZ2Mmg2UFJQMmxQNk11ampjTHdsb3dIMUlZRmhWblVpUEVBd2hEYnVES0JEMko0a0VPaTMxenc5aE9LelB2VTM2SU1GSm1ZaGFNNkpXZEpfZUFwaHNCUEhxVTJPanIxaWQxYTRHMnYtQlVraldrcjd0LTBRbjdlVjZ5NGJPTGVpNmRtZnBsalMzS0doZmtaWTN1MFd3UDN4bi0yVlNCbVpFSm4yQV9kR0ZBeGkxbWxDZk5YZWp4NVl1Qi0zaE0?oc=5","date":"2026-02-02","type":"pipeline","source":"TradingView","summary":"Polaryx Therapeutics, Clinical-Stage Developer of Therapies for Lysosomal Storage Disorders, Files for Nasdaq Capital Market IPO - TradingView","headline":"Polaryx Therapeutics, Clinical-Stage Developer of Therapies for Lysosomal Storage Disorders, Files for Nasdaq Capital Ma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxOSWwzc3l2V1F4enZubWUtYXFUMENmakJGalkwX1BjMnM0UkFEbFZSeXU0Z2tWaDhtdFl3M2RiT0J3bGRaWWhpdEVERndJa1FHYXhZYzBOWUdjcnVCTkJ4WDhyMnRDNXM3ZnU1djlXT0JhYlYxa0ZkcExsd1VVV25Rbl9NRGZ2b1NSNy1NQlZGWjh6VHZtX0U5WkI4M2Z3NnlsMUNxRlkxTUlVY09FWWpOeGM4c09DenpXaDBYLQ?oc=5","date":"2026-02-02","type":"pipeline","source":"Stock Titan","summary":"Rare-disease drug developer Polaryx makes Nasdaq debut today - Stock Titan","headline":"Rare-disease drug developer Polaryx makes Nasdaq debut today","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE5pZzUyRC1QQ2t4dlJPSEkwdk02VEpaUnpWQU5sTVpUZ0hLN2JjR3VYbmxXdndfZG1RTUk0RTNVaVNkWU1RRFNabUpZUnZEYklqLTVJ?oc=5","date":"2026-01-30","type":"pipeline","source":"Stock Titan","summary":"PLYX Stock Price, News & Analysis - Stock Titan","headline":"PLYX Stock Price, News & Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxQQThhVEdORFlqbFlGdThmTExKVXZtenlfdUx6M0VPYTRmZ3RQSVRvcXJSNWNmOFhyTTVud25HTjRVaTA0Yjdta1VwTjAwVUFPQjgxaXlCNnVPSThyOVBFZGhjempzN0JUYmtYUkJSYTJqdHF0UDN4ZTZYVXZKUE1GVkQ5R0FzTHlKaTZrazFNdVNrZjR6Qld3cWdqdURGR2hy?oc=5","date":"2025-11-25","type":"pipeline","source":"Seeking Alpha","summary":"Polaryx Therapeutics Seeks Direct Listing For Shareholders (PLYX) - Seeking Alpha","headline":"Polaryx Therapeutics Seeks Direct Listing For Shareholders (PLYX)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4gFBVV95cUxPd1dsa0dpSXhtNW1NdU9pTWNvNWdBNVBDTVRRempDeWhzdUpTNE1XWFI3UjNpNUhCa0tsczJRdE5qV2JCcGZJSG84QXJ4TDRIaG1XeDRINjNzYy1sbGRlNXNhMmNFREotZ1dsdlVtNEVYRHY2Z3ZuZThCcml1MEwtZHU2VV85U29IZ2c1MnZsa3U2MmVzRElZbjFQVVNzZVFYWE5lLTh6R2M0UjJDMjhsY0Y2VktpRHJGYndxUXZ0ekJJVldzQ3YyX0doTHJIbTkzcVpJWmNhSXowOHFjczRCdVlR?oc=5","date":"2023-11-01","type":"pipeline","source":"PharmiWeb.com","summary":"Sandhoff Disease Therapeutics Market is estimated to exhibit a 6% CAGR, bringing its value to US$ 17 - PharmiWeb.com","headline":"Sandhoff Disease Therapeutics Market is estimated to exhibit a 6% CAGR, bringing its value to US$ 17","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":3,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":null,"revenuePeriod":null,"revenueHistory":[],"grossProfit":null,"grossProfitHistory":[],"rdSpend":6266000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-8985000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":5143000,"cashHistory":[],"totalAssets":5170000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}